CardioRenal

CardioRenal Therapeutics is a physician-owned healthcare company that specializes in providing direct access to cardiac, renal, and pulmonary specialty care for skilled nursing communities and post-acute care providers. The company focuses on delivering evidence-based, specialized post-acute care aimed at improving patient outcomes, reducing hospital readmissions, and enabling higher-acuity care in patients' current settings. The company collaborates with cardiologists, pulmonologists, and nephrologists to enhance care team coordination and patient management. Their services include cardiac care, renal care, pulmonology, dialysis, telemedicine, and remote patient monitoring. CardioRenal Therapeutics utilizes an innovative technology platform called Arsana, which offers actionable clinical data to support decision-making and optimize care delivery. Operating nationally, CardioRenal Therapeutics is dedicated to improving patient care quality and outcomes through advanced specialty services and technology-enabled care solutions. Their approach emphasizes rapid on-site specialty care, enhanced collaboration among care teams, and staff education to elevate care quality.

• Employees2
• Founded2013
• Total Funding$3700000